MedEquities Realty Trust (NYSE:MRT) updated its FY 2018 earnings guidance on Friday. The company provided earnings per share guidance of $1.00-1.02 for the period.
A number of research firms recently weighed in on MRT. B. Riley set a $12.00 target price on shares of MedEquities Realty Trust and gave the company a buy rating in a research report on Thursday, August 9th. ValuEngine downgraded shares of MedEquities Realty Trust from a sell rating to a strong sell rating in a research report on Friday, September 14th. Cantor Fitzgerald reaffirmed a neutral rating and issued a $10.00 target price (down previously from $12.00) on shares of MedEquities Realty Trust in a research report on Friday, September 28th. Canaccord Genuity decreased their target price on shares of MedEquities Realty Trust from $13.00 to $12.00 and set an overweight rating for the company in a research report on Thursday, August 9th. Finally, Royal Bank of Canada set a $10.00 target price on shares of MedEquities Realty Trust and gave the company a hold rating in a research report on Sunday, August 12th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and three have given a buy rating to the company. The stock currently has an average rating of Hold and a consensus price target of $11.25.
Shares of MRT opened at $8.73 on Friday. MedEquities Realty Trust has a one year low of $8.25 and a one year high of $12.00. The stock has a market capitalization of $274.66 million, a PE ratio of 7.18 and a beta of 0.65.
MedEquities Realty Trust (NYSE:MRT) last announced its quarterly earnings data on Friday, November 9th. The financial services provider reported ($0.07) EPS for the quarter, missing analysts’ consensus estimates of $0.28 by ($0.35). MedEquities Realty Trust had a net margin of 30.84% and a return on equity of 5.73%. The firm had revenue of $9.68 million during the quarter, compared to the consensus estimate of $17.72 million. On average, sell-side analysts expect that MedEquities Realty Trust will post 1.08 earnings per share for the current year.
In other news, Director Bluemountain Capital Managemen sold 3,955 shares of MedEquities Realty Trust stock in a transaction dated Friday, October 5th. The shares were sold at an average price of $9.13, for a total value of $36,109.15. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In the last three months, insiders sold 233,564 shares of company stock valued at $2,026,401. Insiders own 2.50% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This news story was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this news story on another publication, it was illegally stolen and republished in violation of international copyright & trademark legislation. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2018/11/11/medequities-realty-trust-mrt-updates-fy-2018-earnings-guidance.html.
About MedEquities Realty Trust
MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.
Featured Article: How to Invest in a Bull Market
Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.